These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 11867823

  • 21. Azithromycin increases chloride efflux from cystic fibrosis airway epithelial cells.
    Oliynyk I, Varelogianni G, Schalling M, Asplund MS, Roomans GM, Johannesson M.
    Exp Lung Res; 2009 Apr; 35(3):210-21. PubMed ID: 19337904
    [Abstract] [Full Text] [Related]

  • 22. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.
    Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, Milne D, Fergusson W, Tuffery C, Sexton P, Storey L, Ashton T.
    Lancet; 2012 Aug 18; 380(9842):660-7. PubMed ID: 22901887
    [Abstract] [Full Text] [Related]

  • 23. Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
    Schmitt-Grohé S, Zielen S.
    Paediatr Drugs; 2005 Aug 18; 7(6):353-63. PubMed ID: 16356023
    [Abstract] [Full Text] [Related]

  • 24. Long-term effects of azithromycin in patients with cystic fibrosis.
    Samson C, Tamalet A, Thien HV, Taytard J, Perisson C, Nathan N, Clement A, Boelle PY, Corvol H.
    Respir Med; 2016 Aug 18; 117():1-6. PubMed ID: 27492507
    [Abstract] [Full Text] [Related]

  • 25. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.
    Nguyen D, Emond MJ, Mayer-Hamblett N, Saiman L, Marshall BC, Burns JL.
    Pediatr Pulmonol; 2007 Jun 18; 42(6):533-41. PubMed ID: 17469154
    [Abstract] [Full Text] [Related]

  • 26. Macrolides in cystic fibrosis: is there a role?
    Wolter JM, Seeney SL, McCormack JG.
    Am J Respir Med; 2002 Jun 18; 1(4):235-41. PubMed ID: 14720043
    [Abstract] [Full Text] [Related]

  • 27. Azithromycin increases survival and reduces lung inflammation in cystic fibrosis mice.
    Tsai WC, Hershenson MB, Zhou Y, Sajjan U.
    Inflamm Res; 2009 Aug 18; 58(8):491-501. PubMed ID: 19271151
    [Abstract] [Full Text] [Related]

  • 28. Rapidly progressive lung disease in a patient with cystic fibrosis on long-term azithromycin: possible role of mycoplasma infection.
    Janahi IA, Abdulwahab A, Elshafie Sittana S, Bush A.
    J Cyst Fibros; 2005 Mar 18; 4(1):71-3. PubMed ID: 15752685
    [Abstract] [Full Text] [Related]

  • 29. Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis.
    Tarique AA, Tuladhar N, Kelk D, Begum N, Lucas RM, Luo L, Stow JL, Wainwright CE, Bell SC, Sly PD, Fantino E.
    Cells; 2024 Jan 16; 13(2):. PubMed ID: 38247856
    [Abstract] [Full Text] [Related]

  • 30. Steady-State Therapy with Azithromycin or Low-Dose Prednisolone in Paediatric Cystic Fibrosis Patients: Inflammatory Markers and Disease Progression.
    Shmarina G, Pukhalsky A, Avakian L, Semykin S, Pukhalskaya D, Alioshkin V.
    Int Arch Allergy Immunol; 2017 Jan 16; 172(1):45-54. PubMed ID: 28219060
    [Abstract] [Full Text] [Related]

  • 31. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
    Phaff SJ, Tiddens HA, Verbrugh HA, Ott A.
    J Antimicrob Chemother; 2006 Apr 16; 57(4):741-6. PubMed ID: 16469851
    [Abstract] [Full Text] [Related]

  • 32. Buccal adherence of Pseudomonas aeruginosa in patients with cystic fibrosis under long-term therapy with azithromycin.
    Baumann U, Fischer JJ, Gudowius P, Lingner M, Herrmann S, Tümmler B, von der Hardt H.
    Infection; 2001 Apr 16; 29(1):7-11. PubMed ID: 11261763
    [Abstract] [Full Text] [Related]

  • 33. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA, Wolfs TF, Fleer A, Kimpen JL, van der Ent CK.
    Pediatr Infect Dis J; 2007 Jan 16; 26(1):8-12. PubMed ID: 17195698
    [Abstract] [Full Text] [Related]

  • 34. Quantifying Long-Term Changes in Lung Function and Exacerbations after Initiation of Azithromycin in Cystic Fibrosis.
    Denis A, Touzet S, Diabaté L, Durieu I, Lemonnier L, Poupon-Bourdy S, Iwaz J, Reynaud Q, Rabilloud M.
    Ann Am Thorac Soc; 2020 Feb 16; 17(2):195-201. PubMed ID: 31604024
    [Abstract] [Full Text] [Related]

  • 35. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K, Sands D.
    Dev Period Med; 2015 Feb 16; 19(1):66-79. PubMed ID: 26003072
    [Abstract] [Full Text] [Related]

  • 36. Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung.
    Segal LN, Clemente JC, Wu BG, Wikoff WR, Gao Z, Li Y, Ko JP, Rom WN, Blaser MJ, Weiden MD.
    Thorax; 2017 Jan 16; 72(1):13-22. PubMed ID: 27486204
    [Abstract] [Full Text] [Related]

  • 37. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.
    Lands LC, Stanojevic S.
    Cochrane Database Syst Rev; 2013 Jun 13; (6):CD001505. PubMed ID: 23765216
    [Abstract] [Full Text] [Related]

  • 38. Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa.
    Saiman L, Mayer-Hamblett N, Anstead M, Lands LC, Kloster M, Goss CH, Rose LM, Burns JL, Marshall BC, Ratjen F, AZ0004 Macrolide Study Team.
    Pediatr Pulmonol; 2012 Jul 13; 47(7):641-8. PubMed ID: 22684984
    [Abstract] [Full Text] [Related]

  • 39. A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.
    Chuchalin A, Csiszér E, Gyurkovics K, Bartnicka MT, Sands D, Kapranov N, Varoli G, Monici Preti PA, Mazurek H.
    Paediatr Drugs; 2007 Jul 13; 9 Suppl 1():21-31. PubMed ID: 17536872
    [Abstract] [Full Text] [Related]

  • 40. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
    Baxter CG, Rautemaa R, Jones AM, Webb AK, Bull M, Mahenthiralingam E, Denning DW.
    Thorax; 2013 Jul 13; 68(7):652-7. PubMed ID: 23513028
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.